vs
Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and ACADIA PHARMACEUTICALS INC (ACAD). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $172.2M, roughly 1.6× Acadian Asset Management Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 20.2%, a 76.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 2.6%). Over the past eight quarters, Acadian Asset Management Inc.'s revenue compounded faster (27.6% CAGR vs 17.5%).
United Asset Management was an American holding company headquartered in Boston, Massachusetts.
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
AAMI vs ACAD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $172.2M | $284.0M |
| Net Profit | $34.7M | $273.6M |
| Gross Margin | — | 90.8% |
| Operating Margin | 33.3% | 6.1% |
| Net Margin | 20.2% | 96.3% |
| Revenue YoY | 2.6% | 9.4% |
| Net Profit YoY | -18.4% | 90.3% |
| EPS (diluted) | $0.97 | $1.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.2M | $284.0M | ||
| Q3 25 | $144.2M | $278.6M | ||
| Q2 25 | $127.4M | $264.6M | ||
| Q1 25 | $119.9M | $244.3M | ||
| Q4 24 | $167.8M | $259.6M | ||
| Q3 24 | $123.1M | $250.4M | ||
| Q2 24 | $109.0M | $242.0M | ||
| Q1 24 | $105.7M | $205.8M |
| Q4 25 | $34.7M | $273.6M | ||
| Q3 25 | $15.1M | $71.8M | ||
| Q2 25 | $10.1M | $26.7M | ||
| Q1 25 | $20.1M | $19.0M | ||
| Q4 24 | $42.5M | $143.7M | ||
| Q3 24 | $16.9M | $32.8M | ||
| Q2 24 | $11.0M | $33.4M | ||
| Q1 24 | $14.6M | $16.6M |
| Q4 25 | — | 90.8% | ||
| Q3 25 | — | 92.2% | ||
| Q2 25 | — | 92.2% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 91.6% | ||
| Q3 24 | — | 92.5% | ||
| Q2 24 | — | 92.5% | ||
| Q1 24 | — | 88.8% |
| Q4 25 | 33.3% | 6.1% | ||
| Q3 25 | 18.4% | 12.8% | ||
| Q2 25 | 12.7% | 12.2% | ||
| Q1 25 | 26.6% | 7.9% | ||
| Q4 24 | 38.7% | 59.1% | ||
| Q3 24 | 21.9% | 12.6% | ||
| Q2 24 | 18.9% | 12.6% | ||
| Q1 24 | 21.7% | 7.4% |
| Q4 25 | 20.2% | 96.3% | ||
| Q3 25 | 10.5% | 25.8% | ||
| Q2 25 | 7.9% | 10.1% | ||
| Q1 25 | 16.8% | 7.8% | ||
| Q4 24 | 25.3% | 55.4% | ||
| Q3 24 | 13.7% | 13.1% | ||
| Q2 24 | 10.1% | 13.8% | ||
| Q1 24 | 13.8% | 8.0% |
| Q4 25 | $0.97 | $1.61 | ||
| Q3 25 | $0.42 | $0.42 | ||
| Q2 25 | $0.28 | $0.16 | ||
| Q1 25 | $0.54 | $0.11 | ||
| Q4 24 | $1.11 | $0.86 | ||
| Q3 24 | $0.45 | $0.20 | ||
| Q2 24 | $0.29 | $0.20 | ||
| Q1 24 | $0.37 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $177.7M |
| Total DebtLower is stronger | $200.0M | — |
| Stockholders' EquityBook value | — | $1.2B |
| Total Assets | $677.0M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $177.7M | ||
| Q3 25 | — | $258.0M | ||
| Q2 25 | — | $253.6M | ||
| Q1 25 | — | $217.7M | ||
| Q4 24 | — | $319.6M | ||
| Q3 24 | — | $155.1M | ||
| Q2 24 | — | $177.1M | ||
| Q1 24 | — | $204.7M |
| Q4 25 | $200.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $275.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $917.3M | ||
| Q2 25 | — | $822.4M | ||
| Q1 25 | — | $765.2M | ||
| Q4 24 | — | $732.8M | ||
| Q3 24 | — | $577.2M | ||
| Q2 24 | — | $516.7M | ||
| Q1 24 | — | $464.0M |
| Q4 25 | $677.0M | $1.6B | ||
| Q3 25 | $751.4M | $1.3B | ||
| Q2 25 | $672.3M | $1.2B | ||
| Q1 25 | $677.3M | $1.1B | ||
| Q4 24 | $703.2M | $1.2B | ||
| Q3 24 | $555.2M | $976.9M | ||
| Q2 24 | $533.1M | $914.1M | ||
| Q1 24 | $544.9M | $855.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $-48.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.07× | -0.18× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | $-48.7M | ||
| Q3 25 | $-23.9M | $74.3M | ||
| Q2 25 | $61.6M | $64.0M | ||
| Q1 25 | $-48.8M | $20.3M | ||
| Q4 24 | $55.8M | $40.4M | ||
| Q3 24 | $69.6M | $63.2M | ||
| Q2 24 | $45.7M | $25.0M | ||
| Q1 24 | $-40.4M | $29.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $73.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $63.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.07× | -0.18× | ||
| Q3 25 | -1.58× | 1.03× | ||
| Q2 25 | 6.10× | 2.40× | ||
| Q1 25 | -2.43× | 1.07× | ||
| Q4 24 | 1.31× | 0.28× | ||
| Q3 24 | 4.12× | 1.93× | ||
| Q2 24 | 4.15× | 0.75× | ||
| Q1 24 | -2.77× | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAMI
Segment breakdown not available.
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
